UbcH5b/UBE2D2 Antibody (4A1)

This product is produced by and distributed for Abnova, a company based in Taiwan.

The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme functions in the ubiquitination of the tumor-suppressor protein p53, which is induced by an E3 ubiquitin-protein ligase. Two alternatively spliced transcript variants have been found for this gene and they encode distinct isoforms.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 2 of 2.

Publications using H00007322-M02	Applications	Species
Huan-Yun C, Chia-Lang H, Han-Yi L et al. Clinical and functional characterization of a novel STUB1 frameshift mutation in autosomal dominant spinocerebellar ataxia type 48 (SCA48). J Biomed Sci. 2021-09-26 [PMID: 34565360]
Peters CJ, Rees JR, Hardwick RH et al. A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology. 2009-01-01 [PMID: 20621683]

Array H00007322-M02

• UbcH5b/UBE2D2 Antibodies
• UbcH5b/UBE2D2 Lysates
• UbcH5b/UBE2D2 Protein
• UbcH5b/UBE2D2 Proteins and Enzyme